We are live on ! Find out more
PCM

Penserra Capital Management Portfolio holdings

AUM $8.52B
1-Year Est. Return 37.76%
This Fund
S&P 500
This Quarter Est. Return
+19.89%
1 Year Est. Return
+37.76%
3 Year Est. Return
+116.32%
5 Year Est. Return
+122.1%
10 Year Est. Return
+1,892.45%
AUM
$7.17B
AUM Growth
+$1.55B
Cap. Flow
+$634M
Cap. Flow %
8.85%
Top 10 Hldgs %
20.13%
Holding
1,164
New
125
Increased
447
Reduced
312
Closed
141

Top Buys

Rank Stock Value
1
RDWR icon
Radware
RDWR
+$68.3M
2
NVDA icon
NVIDIA
NVDA
+$33.6M
3
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
+$33M
4
ORCL icon
Oracle
ORCL
+$29.3M
5
ARM icon
Arm
ARM
+$27.4M

Sector Composition

Rank Sector Weight
1 Technology 55.16%
2 Industrials 5.93%
3 Financials 2.33%
4 Communication Services 2.13%
5 Consumer Discretionary 1.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GILD icon
676
Gilead Sciences
GILD
$165B
$151K ﹤0.01%
1,368
+1,266
+1,241% +$135K
IQV icon
677
IQVIA
IQV
$39.3B
$151K ﹤0.01%
963
+90
+10% +$13.5K
AWK icon
678
American Water Works
AWK
$26.9B
$148K ﹤0.01%
1,070
-1,698
-61% -$243K
ENR icon
679
Energizer
ENR
$1.55B
$148K ﹤0.01%
7,374
+5,351
+265% +$129K
FITB
680
Fifth Third Bancorp
FITB
$51.8B
$148K ﹤0.01%
3,622
+349
+11% +$13.1K
MRK icon
681
Merck
MRK
$318B
$147K ﹤0.01%
1,866
-355
-16% -$28.2K
BRO icon
682
Brown & Brown
BRO
$23.9B
$146K ﹤0.01%
1,326
-19,516
-94% -$2.19M
CNC icon
683
Centene
CNC
$32.5B
$146K ﹤0.01%
2,712
+136
+5% +$7.98K
PFE icon
684
Pfizer
PFE
$153B
$145K ﹤0.01%
6,021
-1,606
-21% -$37.5K
DNA icon
685
Ginkgo Bioworks
DNA
$521M
$143K ﹤0.01%
12,786
+9,271
+264% +$71.8K
SYF icon
686
Synchrony
SYF
$25.6B
$140K ﹤0.01%
2,101
+198
+10% +$11.1K
BTSG icon
687
BrightSpring Health Services
BTSG
$12.4B
$139K ﹤0.01%
+5,922
New +$124K
GVA icon
688
Granite Construction
GVA
$5.62B
$138K ﹤0.01%
+1,482
New +$125K
CAKE icon
689
Cheesecake Factory
CAKE
$5.33B
$137K ﹤0.01%
+2,196
New +$117K
DOV icon
690
Dover
DOV
$28.4B
$137K ﹤0.01%
751
+83
+12% +$14.4K
HLI icon
691
Houlihan Lokey
HLI
$9.02B
$137K ﹤0.01%
+762
New +$128K
SBAC icon
692
SBA Communications
SBAC
$19.5B
$137K ﹤0.01%
587
+65
+12% +$14.9K
TYL icon
693
Tyler Technologies
TYL
$12.8B
$137K ﹤0.01%
234
+30
+15% +$17K
ACM icon
694
Aecom
ACM
$9.75B
$136K ﹤0.01%
+1,206
New +$125K
NWG icon
695
NatWest
NWG
$76.4B
$136K ﹤0.01%
+9,630
New +$127K
AZN icon
696
AstraZeneca
AZN
$250B
$135K ﹤0.01%
967
-625
-39% -$87.6K
MKL icon
697
Markel Group
MKL
$23.2B
$135K ﹤0.01%
68
+10
+17% +$18.8K
RUN icon
698
Sunrun
RUN
$2.46B
$135K ﹤0.01%
16,514
+11,973
+264% +$94.2K
WWD icon
699
Woodward
WWD
$21.4B
$135K ﹤0.01%
+552
New +$113K
CASY icon
700
Casey's General Stores
CASY
$30.9B
$134K ﹤0.01%
+264
New +$122K

Similar funds

Penserra Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Penserra Capital Management held 1,164 positions worth $7.17B, up 28% from $5.61B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Penserra Capital Management deployed $634M of net new capital in Q2 2025, opening 125 new positions and adding to 447 existing holdings. Its largest new stake was Radware: 2,885,913 shares worth $85M.

By sector, the portfolio is most concentrated in Technology at 55% of assets, up from 45% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was D-Wave Quantum Inc. Common Stock, an estimated $45.9M trimmed.

  • Penserra Capital Management's largest Q2 2025 buy was Radware: 2,885,913 shares worth $85M.
  • Penserra Capital Management added most to NVIDIA in Q2 2025, an estimated $33.6M increase.
  • Penserra Capital Management's biggest Q2 2025 reduction was D-Wave Quantum Inc. Common Stock, cutting an estimated $45.9M.
  • Penserra Capital Management fully exited Fastly Inc in Q2 2025, selling an estimated $45.4M.
  • Penserra Capital Management's ten largest holdings make up 20% of its $7.17B portfolio in Q2 2025.
  • Penserra Capital Management opened 125 new positions and closed 141 in Q2 2025.
  • Penserra Capital Management's portfolio value rose 28% quarter-over-quarter to $7.17B.

Based on Penserra Capital Management's 13F filing for Q2 2025, filed 6 Aug 2025.